Pharmacokinetics and Safety of Voriconazole Intravenous-to-Oral Switch Regimens in Immunocompromised Japanese Pediatric Patients
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pharmacokinetics and Safety of Voriconazole Intravenous-to-Oral Switch Regimens in Immunocompromised Japanese Pediatric Patients
Authors
Keywords
-
Journal
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Volume 59, Issue 2, Pages 1004-1013
Publisher
American Society for Microbiology
Online
2014-12-02
DOI
10.1128/aac.04093-14
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Population Pharmacokinetic Analysis of Voriconazole and Anidulafungin in Adult Patients with Invasive Aspergillosis
- (2014) Ping Liu et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Voriconazole therapeutic drug monitoring: retrospective cohort study of the relationship to clinical outcomes and adverse events
- (2013) Helen Y Chu et al. BMC INFECTIOUS DISEASES
- Therapeutic drug monitoring of voriconazole and posaconazole for invasive aspergillosis
- (2013) Seyedmojtaba Seyedmousavi et al. Expert Review of Anti-Infective Therapy
- Practice guidelines for therapeutic drug monitoring of voriconazole: a consensus review of the Japanese Society of Chemotherapy and the Japanese Society of Therapeutic Drug Monitoring
- (2013) Yukihiro Hamada et al. JOURNAL OF INFECTION AND CHEMOTHERAPY
- Nationwide survey of treatment for pediatric patients with invasive fungal infections in Japan
- (2013) Masaaki Mori JOURNAL OF INFECTION AND CHEMOTHERAPY
- Prospective, Observational Study of Voriconazole Therapeutic Drug Monitoring among Lung Transplant Recipients Receiving Prophylaxis: Factors Impacting Levels of and Associations between Serum Troughs, Efficacy, and Toxicity
- (2012) Dimitra Mitsani et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Multicenter Study of Voriconazole Pharmacokinetics and Therapeutic Drug Monitoring
- (2012) Michael J. Dolton et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Integrated Population Pharmacokinetic Analysis of Voriconazole in Children, Adolescents, and Adults
- (2012) Lena E. Friberg et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The Effect of Therapeutic Drug Monitoring on Safety and Efficacy of Voriconazole in Invasive Fungal Infections: A Randomized Controlled Trial
- (2012) Wan Beom Park et al. CLINICAL INFECTIOUS DISEASES
- ESCMID* *This guideline was presented in part at ECCMID 2011. European Society for Clinical Microbiology and Infectious Diseases. guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients
- (2012) O.A. Cornely et al. CLINICAL MICROBIOLOGY AND INFECTION
- Investigation and threshold of optimum blood concentration of voriconazole: a descriptive statistical meta-analysis
- (2012) Yukihiro Hamada et al. JOURNAL OF INFECTION AND CHEMOTHERAPY
- A retrospective analysis of voriconazole pharmacokinetics in Japanese pediatric and adolescent patients
- (2012) Masaaki Mori et al. JOURNAL OF INFECTION AND CHEMOTHERAPY
- Monitoring trough voriconazole plasma concentrations in haematological patients: real life multicentre experience
- (2012) Zdenek Racil et al. MYCOSES
- Comparison of Pharmacokinetics and Safety of Voriconazole Intravenous-to-Oral Switch in Immunocompromised Children and Healthy Adults
- (2011) Timothy A. Driscoll et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Comparison of Pharmacokinetics and Safety of Voriconazole Intravenous-to-Oral Switch in Immunocompromised Adolescents and Healthy Adults
- (2011) Timothy A. Driscoll et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Observational Study of the Clinical Efficacy of Voriconazole and Its Relationship to Plasma Concentrations in Patients
- (2011) Peter F. Troke et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Voriconazole Pharmacokinetics and Safety in Immunocompromised Children Compared to Adult Patients
- (2010) C. Michael et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacokinetics, Safety, and Tolerability of Voriconazole in Immunocompromised Children
- (2010) T. J. Walsh et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3—2009 Update
- (2010) J Maertens et al. BONE MARROW TRANSPLANTATION
- Clinical Practice Guidelines for the Management of Candidiasis: 2009 Update by the Infectious Diseases Society of America
- (2009) Peter G. Pappas et al. CLINICAL INFECTIOUS DISEASES
- Voriconazole Pharmacokinetics and Pharmacodynamics in Children
- (2009) Michael Neely et al. CLINICAL INFECTIOUS DISEASES
- Voriconazole concentrations and outcome of invasive fungal infections
- (2009) S. Miyakis et al. CLINICAL MICROBIOLOGY AND INFECTION
- In Vitro Hepatic Metabolism Explains Higher Clearance of Voriconazole in Children versus Adults: Role of CYP2C19 and Flavin-Containing Monooxygenase 3
- (2009) S. B. Yanni et al. DRUG METABOLISM AND DISPOSITION
- Monitoring trough concentration of voriconazole is important to ensure successful antifungal therapy and to avoid hepatic damage in patients with hematological disorders
- (2009) Koki Ueda et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Pharmacokinetics and tolerability of voriconazole and a combination oral contraceptive co-administered in healthy female subjects
- (2008) Emma Andrews et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America
- (2008) Thomas J. Walsh et al. CLINICAL INFECTIOUS DISEASES
- Voriconazole Therapeutic Drug Monitoring in Patients with Invasive Mycoses Improves Efficacy and Safety Outcomes
- (2007) A. Pascual et al. CLINICAL INFECTIOUS DISEASES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now